Background Little is known about the psychological outcomes of germline multigene panel
testing, particularly among diverse patients and those with moderate‐risk pathogenic …

Variants of uncertain significance (VUSs) are often disclosed to patients despite ambiguous
association with disease risk and lack of clinical actionability. It is important to understand …

Genetic variants of uncertain significance (VUSs) pose a growing challenge for patient
communication and care in precision genomic medicine. To better understand patient …

Abstract Background and Aim Serrated polyposis syndrome (SPS) is now known to be the
commonest polyposis syndrome. Previous analyses for germline variants have shown no …

Effective narrative turn of doctor‐patient communication can strengthen the trust between
doctors and patients, close the doctor‐patient relationship, and reduce the contradiction …

Engaging with the public for their input about genomic medicine is critical before it is
implemented into routine healthcare practice. In order to inform discussion and planning for …

Genomic testing is a critical component of precision medicine. It has influenced many
aspects of patient care, including diagnosis, disease monitoring, and treatment choice …

Abstract Purpose of Review The availability of multigene cancer panel testing (MCPT) has
revolutionized the care of individuals and families at risk for hereditary cancer. This review …

Navigating the uncertainty: Experiences of patients with pathogenic or likely pathogenic variants
in ATM and CHEK2 Master’s Th Page 1 Navigating the uncertainty: Experiences of patients …